Anti-Cancer Drugs, Anti-Infectives Added To National List Of Essential Medicines

Several antibiotics, vaccines and anti-cancer drugs will become more affordable by their addition to the list.

A salesperson arranges medicine at a private pharmacy (Source: File photo/AFP)

New Delhi: Thirty-four drugs, including some anti-infectives such as Ivermectin, Mupirocin and Nicotine Replacement Therapy, have been added to the National List of Essential Medicines taking the total number of drugs under it to 384. Several antibiotics, vaccines and anti-cancer drugs will become more affordable by their addition to the list. However, 26 drugs such as Ranitidine, Sucralfate, white petrolatum, Atenolol and Methyldopa have been deleted from the revised list.

The deletion has been done based on the parameters of cost-effectiveness and availability of better drugs.

Union Health Minister Mansukh Mandaviya, who released the list on Tuesday, tweeted, "Released the National List of Essential Medicines 2022. It comprises 384 drugs across 27 categories. Several antibiotics, vaccines, anti-cancer drugs and many other important drugs will become more affordable & reduce patients’ out-of-pocket expenditure."

Endocrine medicines and contraceptives Fludrocortisone, Ormeloxifene, Insulin Glargine and Teneliglitin have been added to the list. Montelukast, which acts on the respiratory tract, and the ophthalmological drug Latanoprost figure in the list. Cardiovascular medicines Dabigatran and Tenecteplase also find a place in the list besides medicines used in palliative care.

"Antinfectives such as Ivermectine, Meropenem, Cefuroxime, Amikacin, Bedaquiline, Delamanid, Itraconazole ABC Dolutegravir have been added to the NLM," Dr. Y K Gupta, Vice Chairman of the Standing National Committee on Medicines, said.

The drugs in NLEM are included in the scheduled category and their price is regulated by the National Pharmaceutical Pricing Authority, Dr. Gupta said.

A revised list of 399 formulations was submitted by an expert committee under the Indian Council of Medical Research (ICMR) last year. After a detailed analysis of Indian requirements, major changes were sought by Mandaviya.

(This report has been published as part of the auto-generated syndicate wire feed. Apart from the headline, no editing has been done in the copy by ABP Live.)